A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer
| Image |  |
|---|---|
| Description | scientific article published on 05 October 2020 |
| Author/s |
author: Ben C Creelan Don L Gibbons |
| Publication date | October 5, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |